Digoxin and Heart Failure: Are We Clear Yet?
The Digoxin Investigation Group trial has multiple flaws in the trial design for the findings to be universally applicable. Digoxin in low serum concentrations (0.5–0.9 ng/mL) has been shown to decrease mortality in heart failure patients. Multiple trials in different patient populations also show b...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Compuscript Ltd
2017-04-01
|
| Series: | Cardiovascular Innovations and Applications |
| Acceso en liña: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2016.0044 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|